Positive Topline Results for Migraine Drug in Two Safety Studies Positive Topline Results for Migraine Drug in Two Safety Studies

With positive efficacy data, two safety studies show that oral ubrogepant, a novel CGRP-targeting medication, is safe and well tolerated for treating acute migraine.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news